Skip to main content

Table 1 Characterization of the study population; 297 patients with positive PCR for Pneumocystis jirovecii

From: Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway

Male sex, n (%)

180 (60.6)

Ever smoking, n (%)

162 (54.5)

Age (years), median, (q1-q3)

66 (59–74)

Immunosuppressive conditions, n (%)

Hematological malignancies

107 (36.0)

  Non-Hodgkin’s lymphoma

55 (18.5)

  Chronic leukemia

17 (5.7)

  Plasma cell disease

15 (5.1)

  Acute leukemia

11 (3.7)

  Hodgkin’s lymphoma

9 (3.0)

Solid tumors

75 (25.3)

  Lung including pleural membranes

27 (9.1)

  Breast

14 (4.7)

  Genitourinary tract

14 (4.7)

  Gastrointestinal tract

9 (3.0)

  Other primary tumora

11 (3.7)

Immunological disorders

46 (15.5)

  Rheumatoid arthritis

16 (5.4)

  Connective tissue disorders and vasculitidies

15 (5.1)

  Miscellaneousb disorders

15 (5.1)

Solid organ transplantations

37 (12.5)

  Kidney

31 (10.4)

  Heart, lung

6 (2.0)

Chronic lung diseases

18 (6.1)

  Interstitial lung disease or sarcoidosis

11 (3.7)

  Chronic obstructive pulmonary disease

7 (2.4)

HIV-infection

7 (2.4)

Otherc

7 (2.4)

Comorbid conditions, n (%)

 Hypertension

92 (31.0)

 Cardiovascular disease

83 (27.9)

 Chronic pulmonary disease

52 (17.5)

 Diabetes mellitus type 1 or 2

44 (14.8)

 Solid tumor

30 (10.1)

 Chronic kidney disease

38 (12.8)

 Congestive heart failure

18 (6.1)

 Rheumatic disease

12 (4.0)

 Hematological malignancyd

13 (4.4)

 Chronic liver disease

4 (1.4)

Charlson comorbidity index, n (%)

  < 4

47 (15.8)

 4–6

132 (44.4)

  > 6

118 (39.7)

  1. Abbreviations: AIHA autoimmune hemolytic anemia, ITP immune thrombocytopenic purpura, PCR polymerase chain reaction
  2. aOther primary tumors include brain tumors (i.e., astroglioma, meningioma), nasopharyngeal carcinoma, melanoma, adrenal gland tumor, sarcoma, and mesothelioma
  3. bMiscellaneous immunological disorders include hematological disorders (ITP, AIHA), skin disorders, uveitis, inflammatory diseases of gastrointestinal tract and arthritidies other than rheumatoid arthritis
  4. cOther immunosuppressive conditions include one patient with statin-induced myositis, one patient with common variable immunodeficiency and four patients with no established disorder at the time of presentation
  5. dIn 13 patients, hematological malignancy was not considered the primary immunosuppressive condition nor indication for immunosuppression but rather comorbidity